Viewing Study NCT00050232


Ignite Creation Date: 2025-12-24 @ 9:37 PM
Ignite Modification Date: 2025-12-25 @ 7:20 PM
Study NCT ID: NCT00050232
Status: COMPLETED
Last Update Posted: 2016-07-14
First Post: 2002-12-02
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Safety and Efficacy of AVP-923 for Pseudobulbar Affect in Multiple Sclerosis Patients
Sponsor: Avanir Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module